Advanced Biomed Common Stock Statistics Share Statistics Advanced Biomed Common Stock has 21.64M
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding 21.64M Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) n/a Shares Floating n/a Failed to Deliver (FTD) Shares 244 FTD / Avg. Volume 0.13%
Short Selling Information The latest short interest is 70.85K, so 0.33% of the outstanding
shares have been sold short.
Short Interest 70.85K Short % of Shares Out 0.33% Short % of Float 0.77% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -26.24 and the forward
PE ratio is null.
Advanced Biomed Common Stock's PEG ratio is
1.
PE Ratio -26.24 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 43.89 P/FCF Ratio -33.18 PEG Ratio 1
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Advanced Biomed Common Stock.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.12,
with a Debt / Equity ratio of 0.08.
Current Ratio 1.12 Quick Ratio 1.12 Debt / Equity 0.08 Debt / EBITDA -0.06 Debt / FCF -0.06 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-69.56K Employee Count 40 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is 1.51, so Advanced Biomed Common Stock's
price volatility has been higher than the market average.
Beta 1.51 52-Week Price Change n/a 50-Day Moving Average 0.83 200-Day Moving Average n/a Relative Strength Index (RSI) 29.63 Average Volume (20 Days) 189,163
Income Statement
Revenue n/a Gross Profit n/a Operating Income -2.54M Net Income -2.78M EBITDA -2.14M EBIT -2.54M Earnings Per Share (EPS) -0.14
Full Income Statement Balance Sheet The company has 2.61M in cash and 126.74K in
debt, giving a net cash position of 2.48M.
Cash & Cash Equivalents 2.61M Total Debt 126.74K Net Cash 2.48M Retained Earnings -15.97M Total Assets 8.29M Working Capital 3.62M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -2.13M
and capital expenditures -74.11K, giving a free cash flow of -2.2M.
Operating Cash Flow -2.13M Capital Expenditures -74.11K Free Cash Flow -2.2M FCF Per Share -0.11
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
